Michael Scolaro

Michael Scolaro

Dec 23, 2017

Group 6 Copy 917
5
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Circulating biomarkers of fibrosis in captive gorillas: a pilot study

Heart disease is the leading cause of death for gorillas in captivity. The ultimate goal of this project...

A Leap Forward to Cure a Neglected Disease

The World Health Organization estimates that as many as 11 million people worldwide are infected with the...

Are Emergency Doctors Uncomfortable Treating Patients in Psychiatric Crisis? If so, Why?

This survey research study aims to explore the amount of confidence emergency physicians have with treating...

Backer Badge Funded